Author:
Joram Sunguti Luke,Paul Gathii,Moses Kitheka,Stanley Bii,Isaac Malonza,Allan Gohole,Tom Marwa,Lilian Karimi,Mildred Mudany
Funder
United States Agency for International Development
Publisher
Springer Science and Business Media LLC
Reference19 articles.
1. National AIDS Control Council (NACC), Kenya. Kenya AIDS Response Progress Report 2016. Nairobi, NACC. October 2016. Available at:
http://nacc.or.ke/wp-content/uploads/2016/11/Kenya-AIDS-Progress-Report_web.pdf
2. Ministry of Health; National AIDS and STI Control Program (NASCOP). Guidelines on Use of Antiretroviral Drugs for Treating and Preventing HIV Infection: A rapid advice, 2014. Available at:
https://aidsfree.usaid.gov/sites/default/files/tx_kenya_2014.pdf
.
3. Elul B, Basinga P, Nuwagaba-Biribonwoha H, Saito S, Horowitz D, Nash D, et al. High levels of adherence and viral suppression in a nationally representative sample of HIV-infected adults on antiretroviral therapy for 6, 12 and 18 months in Rwanda. 2013;8(1):e53586.
4. Kabugo C, Bahendeka S, Mwebaze R, Malamba S, Katuntu D, Downing R, et al. Long-term experience providing antiretroviral drugs in a fee-for-service HIV clinic in Uganda: evidence of extended virologic and CD4+ cell count responses. J Acquir Immune Defic Syndr. 2005;38(5):578–83.
5. Hamers RL, Wallis CL, Kityo C, Siwale M, Mandaliya K, Conradie F, et al. HIV-1 drug resistance in antiretroviral-naive individuals in sub-Saharan Africa after rollout of antiretroviral therapy: a multicentre observational study. Lancet Infect dis. 2011;11(10):750–9.
Cited by
11 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献